KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) Debt to Equity (2016 - 2025)

Historic Debt to Equity for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $0.8.

  • Merck's Debt to Equity fell 685.31% to $0.8 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.8, marking a year-over-year decrease of 685.31%. This contributed to the annual value of $0.8 for FY2024, which is 1408.11% down from last year.
  • Latest data reveals that Merck reported Debt to Equity of $0.8 as of Q3 2025, which was down 685.31% from $0.72 recorded in Q2 2025.
  • Merck's Debt to Equity's 5-year high stood at $1.16 during Q1 2021, with a 5-year trough of $0.66 in Q1 2023.
  • Its 5-year average for Debt to Equity is $0.81, with a median of $0.8 in 2025.
  • Per our database at Business Quant, Merck's Debt to Equity plummeted by 3283.26% in 2022 and then soared by 3978.23% in 2023.
  • Quarter analysis of 5 years shows Merck's Debt to Equity stood at $0.87 in 2021, then dropped by 22.99% to $0.67 in 2022, then surged by 39.78% to $0.93 in 2023, then fell by 14.08% to $0.8 in 2024, then decreased by 0.4% to $0.8 in 2025.
  • Its last three reported values are $0.8 in Q3 2025, $0.72 for Q2 2025, and $0.72 during Q1 2025.